US5622871A
(en)
|
1987-04-27 |
1997-04-22 |
Unilever Patent Holdings B.V. |
Capillary immunoassay and device therefor comprising mobilizable particulate labelled reagents
|
US6406920B1
(en)
*
|
1980-06-20 |
2002-06-18 |
Inverness Medical Switzerland Gmbh |
Processes and apparatus for carrying out specific binding assays
|
NL185309C
(nl)
*
|
1980-07-28 |
1990-03-01 |
Akzo Nv |
Methode voor het bepalen van antigenen met behulp van twee of meer monoklonale antilichamen alsmede immuunreagens.
|
JPS57136165A
(en)
*
|
1981-02-18 |
1982-08-23 |
Mochida Pharmaceut Co Ltd |
Immunological measuring reagent
|
GB2118300B
(en)
*
|
1982-02-12 |
1985-06-19 |
Corning Glass Works |
Method of immunoassay
|
US4663278A
(en)
*
|
1982-04-30 |
1987-05-05 |
Syva Company |
Agglutination dependent enzyme channeling immunoassay
|
US4514505A
(en)
*
|
1982-05-21 |
1985-04-30 |
The Trustees Of Columbia University In The City Of New York |
Monoclonal antibody mixtures and use thereof for enhanced sensitivity immunoassays
|
US4596771A
(en)
*
|
1982-09-27 |
1986-06-24 |
Research Corporation |
Monoclonal antibodies to vitamin B-6 and immunossay method
|
US5219730A
(en)
*
|
1982-09-28 |
1993-06-15 |
New York University |
Idiotype-anti-idiotype immunoassay
|
US4558006A
(en)
*
|
1983-02-04 |
1985-12-10 |
Kirin-Amgen, Inc. |
A.T.C.C. HB8209 and its monoclonal antibody to erythropoietin
|
US4474892A
(en)
*
|
1983-02-16 |
1984-10-02 |
Board Of Trustees Of The Leland Stanford Junior University |
Two-site immunoassays using monoclonal antibodies of different classes or subclasses and test kits for performing same
|
US4939240A
(en)
*
|
1983-03-04 |
1990-07-03 |
Health Research, Inc. |
Monoclonal antibodies to human breast carcinoma cells and their use in diagnosis and therapy
|
US4828981A
(en)
*
|
1983-08-24 |
1989-05-09 |
Synbiotics Corporation |
Immunoassays for determining Dirofilaria immitis infection using antiidiotype monoclonal antibody reagents
|
GB8327860D0
(en)
*
|
1983-10-18 |
1983-11-16 |
Fujisawa Pharmaceutical Co |
Monoclonal antiprotein c antibody
|
AU3745285A
(en)
*
|
1983-11-29 |
1985-06-13 |
Igen, Inc. |
Method of catalyzing chemical reactions
|
US5156965A
(en)
*
|
1983-11-29 |
1992-10-20 |
Igen, Inc. |
Catalytic antibodies
|
US5011771A
(en)
*
|
1984-04-12 |
1991-04-30 |
The General Hospital Corporation |
Multiepitopic immunometric assay
|
US4745075A
(en)
*
|
1984-09-06 |
1988-05-17 |
Burroughs Wellcome Co. |
Diagnostic test methods
|
US4562003A
(en)
*
|
1984-10-26 |
1985-12-31 |
California Biotechnology, Inc. |
Monoclonal antibodies against alveolar surfactant protein
|
US4902614A
(en)
*
|
1984-12-03 |
1990-02-20 |
Teijin Limited |
Monoclonal antibody to human protein C
|
US4888279A
(en)
*
|
1984-12-21 |
1989-12-19 |
Thomas Jefferson University |
Novel immunosorbent assays employing antibiotic keying agents
|
AU590746B2
(en)
*
|
1985-03-06 |
1989-11-16 |
Fuji Yakuhin Kogyo Kabushiki Kaisha |
Method for determining human prolyl 4-hydroxylase by immunoassay
|
CA1272127A
(fr)
*
|
1985-04-04 |
1990-07-31 |
Hybritech Incorporated |
Systeme de dosage ligand-recepteur en phase solide
|
US4824784A
(en)
*
|
1985-04-08 |
1989-04-25 |
Hygeia Sciences, Incorporated |
Chromogenic solution for immunoassay
|
US4935339A
(en)
*
|
1985-05-07 |
1990-06-19 |
Nichols Institute Diagnostics |
Delayed solid phase immunologic assay
|
EP0222781A1
(fr)
*
|
1985-06-03 |
1987-05-27 |
American National Red Cross |
Analyse par floculation d'une surface de microtitrage (msf) destine a deceler la presence d'anticorps ou d'antigenes
|
US4931385A
(en)
*
|
1985-06-24 |
1990-06-05 |
Hygeia Sciences, Incorporated |
Enzyme immunoassays and immunologic reagents
|
US5284778A
(en)
*
|
1985-08-12 |
1994-02-08 |
The Trustees Of Columbia University In The City Of New York |
Sensitive bioassay using monoclonal antibodies which bind to hormone-receptor complexes
|
US6083709A
(en)
*
|
1985-08-21 |
2000-07-04 |
Osi Pharmaceuticals, Inc. |
Immunoassay for detection of mutant P53 polypeptide in serum
|
DE3541033A1
(de)
*
|
1985-11-19 |
1987-05-21 |
Boehringer Mannheim Gmbh |
Verfahren zur quantifizierung von zellpopulationen bzw. subpopulationen sowie hierfuer geeignetes reagenz
|
US5912136A
(en)
*
|
1985-11-19 |
1999-06-15 |
Schering Corporation |
Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
|
US5700915A
(en)
*
|
1985-11-19 |
1997-12-23 |
Schering Corporations |
Human interleukin immunopurification processes
|
US5041381A
(en)
|
1986-07-03 |
1991-08-20 |
Schering Corporation |
Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
|
EP0245520B1
(fr)
*
|
1985-11-21 |
1992-09-16 |
Teijin Limited |
Anticorps monoclonal contre la glutathione s-transferase et son utilisation dans le diagnostic du cancer
|
WO1987003690A1
(fr)
*
|
1985-12-10 |
1987-06-18 |
Murex Corporation |
Immunoanalyse de composants de liaison lies a des particules
|
US5236826A
(en)
*
|
1985-12-10 |
1993-08-17 |
Murex Corporation |
Immunoassay for the detection or quantitation of an analyte
|
US5501949A
(en)
*
|
1985-12-10 |
1996-03-26 |
Murex Diagnostics Corporation |
Particle bound binding component immunoassay
|
JPS63501983A
(ja)
*
|
1985-12-12 |
1988-08-04 |
デニソン マニユフアクチユアリング カンパニ− |
試験物質の測定
|
US4868108A
(en)
*
|
1985-12-12 |
1989-09-19 |
Hygeia Sciences, Incorporated |
Multiple-antibody detection of antigen
|
US4741999A
(en)
*
|
1986-02-26 |
1988-05-03 |
The Research Foundation Of State University Of New York |
Monoclonal antibodies useful in the identification of microorganisms causing periodontal disease
|
US4960692A
(en)
*
|
1986-03-18 |
1990-10-02 |
Fisher Scientific Company |
Assay employing binding pair members on particles and on a filter or membrane
|
WO1987006620A1
(fr)
*
|
1986-04-29 |
1987-11-05 |
Murex Corporation |
Kit de diagnostic pour maladies sexuellement transmissibles
|
US4798807A
(en)
*
|
1986-06-24 |
1989-01-17 |
The Regents Of The University Of California |
Monoclonal antibodies and method for detecting dioxins and dibenzofurans
|
JPS6319559A
(ja)
*
|
1986-07-11 |
1988-01-27 |
Fuji Photo Film Co Ltd |
免疫分析方法
|
ES2070820T3
(es)
*
|
1986-08-06 |
1995-06-16 |
Scripps Clinic Res |
Anticuerpos monoclonales especificos de la apolipoproteina b, producidos por dos nuevos hibridomas.
|
FR2602592B1
(fr)
|
1986-08-06 |
1989-06-30 |
Alain Baret |
Utilisation du systeme enzymatique xanthine-oxydase en immuno-analyse, procedes de dosage correspondants et coffrets de reactifs necessaires pour la mise en oeuvre de ces procedes.
|
US5811310A
(en)
*
|
1986-09-30 |
1998-09-22 |
Albert Einstein College Of Medicine Of Yeshiva Univ. |
The Alz-50 monoclonal antibody and diagnostic assay for alzheimer's disease
|
DE3633497A1
(de)
*
|
1986-10-02 |
1988-04-14 |
Hoechst Ag |
Immunometrisches bestimmungsverfahren
|
US5223441A
(en)
|
1986-10-09 |
1993-06-29 |
Syntex (U.S.A.) Inc. |
Receptors for immune complexes
|
US4804626A
(en)
*
|
1986-10-22 |
1989-02-14 |
The General Hospital Corporation |
Immunometric assay for the detection of human chorionic gonadotropin
|
JPH08840B2
(ja)
*
|
1986-11-14 |
1996-01-10 |
興和株式会社 |
抗pciモノクローナル抗体、これを用いた抗pciの精製法及び免疫学的測定法
|
US5206178A
(en)
*
|
1986-11-19 |
1993-04-27 |
Genetic Systems Corporation |
Membrane affinity concentration immunoassay
|
US5187067A
(en)
*
|
1986-12-15 |
1993-02-16 |
Teijin Limited |
Immunological determination of free human protein S and C4bp-protein S complex
|
US4997772A
(en)
*
|
1987-09-18 |
1991-03-05 |
Eastman Kodak Company |
Water-insoluble particle and immunoreactive reagent, analytical elements and methods of use
|
DE3887771C5
(de)
|
1987-04-27 |
2009-06-04 |
Inverness Medical Switzerland Gmbh |
Immunoassays und Vorrichtungen dafür.
|
US4788138A
(en)
*
|
1987-04-30 |
1988-11-29 |
Beckman Instruments, Inc. |
Method to achieve a linear standard curve in a sandwich immunoassay
|
US5089423A
(en)
*
|
1987-05-06 |
1992-02-18 |
Cyberfluor Inc. |
Immunoassay methods and reagents and methods for producing the latter
|
DE3717401A1
(de)
*
|
1987-05-23 |
1988-12-08 |
Behringwerke Ag |
Einschritt-immuntest zur bestimmung von antigen-spezifischen antikoerpern aus einer der immunglobulin-klassen a, m, d oder e und dazu geeignetes mittel
|
US4962023A
(en)
*
|
1987-06-22 |
1990-10-09 |
Louisiana State University, Agricultural And Mechanical College |
Single incubation immuno sorbent assay method using particle labels to detect test antigen specific antibodies in presence of other antibodies
|
FR2617974B1
(fr)
*
|
1987-07-07 |
1992-11-13 |
Stabiligen |
Procede de dosage immunologique par bio- ou chimio- luminescence
|
CA1300499C
(fr)
*
|
1987-08-03 |
1992-05-12 |
Susan J. Danielson |
Reactif insoluble dans l'eau, elements qui en contiennent et methode d'utilisation
|
JPH07107537B2
(ja)
*
|
1987-08-03 |
1995-11-15 |
イーストマン コダック カンパニー |
アビジン−及びビオチン−固定試薬,分析要素並びにその使用法
|
US5236849A
(en)
*
|
1987-08-11 |
1993-08-17 |
Eiji Ishikawa |
Method of high sensitivity immunoassay
|
US4859612A
(en)
*
|
1987-10-07 |
1989-08-22 |
Hygeia Sciences, Inc. |
Metal sol capture immunoassay procedure, kit for use therewith and captured metal containing composite
|
US5061619A
(en)
*
|
1987-11-05 |
1991-10-29 |
Connaught Laboratories Limited |
Immunoassay using antibody-antigen conjugates
|
US5223440A
(en)
*
|
1987-11-17 |
1993-06-29 |
Adeza Biomedical Corporation |
Ex vivo product of conception test to determine abortion
|
CA1312277C
(fr)
*
|
1987-12-18 |
1993-01-05 |
Richard C. Sutton |
Reactifs immobilises par l'avidine et la biotine, elements d'analyse et methodes d'utilisation
|
US4870007A
(en)
*
|
1987-12-18 |
1989-09-26 |
Eastman Kodak Company |
Immobilized biotinylated receptor in test device, kit and method for determining a ligand
|
JPH01165963A
(ja)
*
|
1987-12-23 |
1989-06-29 |
Tosoh Corp |
Cu,Zn−スーパーオキサイド・ディスムターゼの測定方法
|
US4983530A
(en)
*
|
1988-01-29 |
1991-01-08 |
E. I. Du Pont De Nemours And Company |
Sandwich immunoassay for determination of total monoclonal IGG
|
US5427917A
(en)
*
|
1988-02-01 |
1995-06-27 |
Teijin Limited |
Method of determining human acid glutathione S-transferase, reagent, therefor, kit therefor, method of diagnosing cancer in digestive organs, and monoclonal antibody for use therein
|
US5158871A
(en)
*
|
1988-02-12 |
1992-10-27 |
University Of Connecticut |
Method of using magnetic particles for isolating, collecting and assaying diagnostic ligates
|
US5202267A
(en)
*
|
1988-04-04 |
1993-04-13 |
Hygeia Sciences, Inc. |
Sol capture immunoassay kit and procedure
|
US5256532A
(en)
*
|
1988-05-02 |
1993-10-26 |
Zynaxis Technologies, Inc. |
Methods, reagents and test kits for determination of subpopulations of biological entities
|
US6702705B1
(en)
|
1988-05-04 |
2004-03-09 |
Igen International, Inc. |
Prodrugs activated by targeted catalytic proteins
|
US5280106A
(en)
*
|
1988-05-20 |
1994-01-18 |
Liotta Lance A |
Matrix metalloproteinase peptides: role in diagnosis and therapy
|
US5070013A
(en)
*
|
1988-05-31 |
1991-12-03 |
Schering Corporation |
Immunochemical assay for human granulocyte-macrophage colony stimulating factor
|
US5620845A
(en)
*
|
1988-06-06 |
1997-04-15 |
Ampcor, Inc. |
Immunoassay diagnostic kit
|
AU2684488A
(en)
*
|
1988-06-27 |
1990-01-04 |
Carter-Wallace, Inc. |
Test device and method for colored particle immunoassay
|
US5281522A
(en)
*
|
1988-09-15 |
1994-01-25 |
Adeza Biomedical Corporation |
Reagents and kits for determination of fetal fibronectin in a vaginal sample
|
US5681726A
(en)
*
|
1988-09-19 |
1997-10-28 |
Stratagene |
Method of double stranded DNA synthesis
|
EP0390910B1
(fr)
|
1988-10-17 |
1995-12-13 |
Molecular Devices Corporation |
Membrane de capture derive d e haptene et tests de diagnostic utilisant une telle membrane
|
US5888728A
(en)
|
1988-10-17 |
1999-03-30 |
Molecular Devices Corporation |
Hapten derivatized capture membrane and diagnostic assays using such membrane
|
US5079172A
(en)
*
|
1988-11-04 |
1992-01-07 |
Board Of Trustees Operating Michigan State University |
Method for detecting the presence of antibodies using gold-labeled antibodies and test kit
|
US5200051A
(en)
*
|
1988-11-14 |
1993-04-06 |
I-Stat Corporation |
Wholly microfabricated biosensors and process for the manufacture and use thereof
|
US6306594B1
(en)
|
1988-11-14 |
2001-10-23 |
I-Stat Corporation |
Methods for microdispensing patterened layers
|
US5102788A
(en)
*
|
1988-11-21 |
1992-04-07 |
Hygeia Sciences, Inc. |
Immunoassay including lyophilized reactant mixture
|
US6258360B1
(en)
|
1989-05-04 |
2001-07-10 |
Igen International, Inc. |
Prodrugs activated by targeted catalytic proteins
|
WO1990015327A1
(fr)
*
|
1989-06-06 |
1990-12-13 |
Martin Gould |
Kit diagnostic d'immunoanalyse
|
EP0411944B1
(fr)
*
|
1989-08-04 |
1998-06-10 |
BEHRINGWERKE Aktiengesellschaft |
Essais de liaison hétérogènes
|
DE69029270T2
(de)
*
|
1989-09-15 |
1997-03-27 |
Genetic Systems Corp |
HYBRIDOMA CT43, DAS EIN ANTIKöRPER GEGEN EIN MUCINEPITOP VON DARMKREBS ERZEUGT
|
US5202264A
(en)
*
|
1989-10-27 |
1993-04-13 |
Health Research, Incorporated |
ELISA using multi-species antibodies for detection of von Willebrand factor in multiple species
|
US5196311A
(en)
*
|
1989-10-27 |
1993-03-23 |
Health Research, Incorporated |
Elisa test for von willebrand factor
|
US5830709A
(en)
*
|
1989-10-27 |
1998-11-03 |
Benson; Roger E. |
Detection method for homologous portions of a class of substances
|
US5532135A
(en)
*
|
1990-02-02 |
1996-07-02 |
Cancer Research Fund Of Contra Costa |
Solid-phase competitive assay utilizing a fusion protein
|
US6190885B1
(en)
|
1990-02-02 |
2001-02-20 |
Cancer Research Fund Of Contra Costa |
Fusion protein containing HMFG Epitop E (S)
|
US5180828A
(en)
*
|
1990-02-09 |
1993-01-19 |
Molecular Devices Corporation |
Chromophoric reagents for incorporation of biotin or other haptens into macromolecules
|
US5532138A
(en)
*
|
1990-04-26 |
1996-07-02 |
Behringwerke Ag |
Method and kits for determining peroxidatively active catalysts
|
US5252461A
(en)
*
|
1990-05-01 |
1993-10-12 |
The Regents Of The Univ. Of California |
Mixed immunoglobulins for detection of rheumatoid factors
|
US5238851A
(en)
*
|
1990-05-01 |
1993-08-24 |
The Regents Of The Univ. Of California |
Mixed immunoglobulins for detection of rheumatoid factors
|
US5789163A
(en)
|
1990-06-11 |
1998-08-04 |
Nexstar Pharmaceuticals, Inc. |
Enzyme linked oligonucleotide assays (ELONAS)
|
DE69125992T2
(de)
*
|
1990-09-14 |
1997-08-21 |
Tosoh Corp |
Verfahren und Kit für Immunoassay
|
DE69131046T2
(de)
*
|
1990-11-07 |
1999-10-21 |
Abbott Lab |
Monoklonale antikörper gegen den hepatitis c-virus und verfahren diese zu benutzen
|
US5753430A
(en)
*
|
1990-11-07 |
1998-05-19 |
Abbott Laboratories |
Monoclonal antibodies to hepatitis C virus and method for using same
|
US5210017A
(en)
*
|
1990-11-19 |
1993-05-11 |
Genentech, Inc. |
Ligand-mediated immunofunctional hormone binding protein assay method
|
US6326154B1
(en)
|
1990-11-19 |
2001-12-04 |
Genentech, Inc. |
Ligand-mediated immunofunctional hormone binding protein assay method
|
US5593844A
(en)
*
|
1990-11-19 |
1997-01-14 |
Genentech, Inc. |
Ligand-mediated immunofunctional hormone binding protein assay method
|
WO1992009631A1
(fr)
*
|
1990-11-30 |
1992-06-11 |
Abbott Laboratories |
Immunoanalyse et anticorps monoclonaux utilises dans la detection de recepteur de facteur de croissance de nerfs tronques
|
AU657102B2
(en)
*
|
1991-04-12 |
1995-03-02 |
Bio-Rad Laboratories, Inc. |
CA 195-like immunoreactive antigen from human amniotic fluid
|
US5877028A
(en)
|
1991-05-29 |
1999-03-02 |
Smithkline Diagnostics, Inc. |
Immunochromatographic assay device
|
US5998220A
(en)
|
1991-05-29 |
1999-12-07 |
Beckman Coulter, Inc. |
Opposable-element assay devices, kits, and methods employing them
|
US6168956B1
(en)
|
1991-05-29 |
2001-01-02 |
Beckman Coulter, Inc. |
Multiple component chromatographic assay device
|
WO1992022668A1
(fr)
*
|
1991-06-14 |
1992-12-23 |
Vanderbilt University |
Methode et compositions permettant d'evaluer les agressions par oxydation in vivo
|
JP3183666B2
(ja)
*
|
1991-07-19 |
2001-07-09 |
アツセイ・リサーチ・インコーポレーテツド |
内因性サイトカイン類の測定方法およびキット
|
US5965379A
(en)
*
|
1991-07-19 |
1999-10-12 |
Cytimmune Sciences Inc. |
Method for measuring endogenous cytokines
|
EP0597951B1
(fr)
*
|
1991-07-26 |
1999-03-31 |
Dade Chemistry Systems Inc. |
Dosage avec detection de signaux en presence d'un support solide en suspension
|
US5593850A
(en)
*
|
1991-08-30 |
1997-01-14 |
Nalco Chemical Company |
Monitoring of industrial water quality using monoclonal antibodies to polymers
|
EP0575906A2
(fr)
*
|
1992-06-19 |
1993-12-29 |
SHIONOGI SEIYAKU KABUSHIKI KAISHA trading under the name of SHIONOGI & CO. LTD. |
Essai immunologique à liaison double de bêta-N-acétylglucosaminidase et anticorps monoclonal pour l'essai
|
US5837672A
(en)
|
1992-07-10 |
1998-11-17 |
Athena Neurosciences, Inc. |
Methods and compositions for the detection of soluble β-amyloid peptide
|
US5766846A
(en)
*
|
1992-07-10 |
1998-06-16 |
Athena Neurosciences |
Methods of screening for compounds which inhibit soluble β-amyloid peptide production
|
US6610493B1
(en)
*
|
1993-06-17 |
2003-08-26 |
Brigham And Women's Hospital |
Screening compounds for the ability to alter the production of amyloid-β peptide
|
US5447838A
(en)
*
|
1992-08-05 |
1995-09-05 |
Hybritech Incorporated |
Protein-dye conjugate for confirmation of correct dilution of calibrators
|
DE69333076T2
(de)
*
|
1992-12-18 |
2004-04-15 |
Molecular Rx Inc. |
Test und behandlung von demyelinierenden krankheiten wie multiple sklerosis
|
US5914241A
(en)
*
|
1993-01-19 |
1999-06-22 |
Biosite Diagnostics, Inc. |
Assays and kits for detecting analytes in the presence of cross-reacting substances
|
US5374531A
(en)
*
|
1993-03-22 |
1994-12-20 |
Zynaxis, Inc. |
Immunoassay for determination of cells
|
US5807549A
(en)
*
|
1993-05-21 |
1998-09-15 |
Research Corporation Technologies, Inc. |
Lymphocyte chemoattractant factor and uses thereof
|
US6660842B1
(en)
*
|
1994-04-28 |
2003-12-09 |
Tripep Ab |
Ligand/receptor specificity exchangers that redirect antibodies to receptors on a pathogen
|
US6933366B2
(en)
*
|
1996-12-27 |
2005-08-23 |
Tripep Ab |
Specificity exchangers that redirect antibodies to bacterial adhesion receptors
|
US6417324B1
(en)
*
|
2000-04-21 |
2002-07-09 |
Tripep Ab |
Synthetic peptides that bind to the hepatitis B virus core and e antigens
|
US6653066B1
(en)
|
1994-06-17 |
2003-11-25 |
Trinity Biotech |
Device and method for detecting polyvalent substances
|
WO1996005308A1
(fr)
|
1994-08-12 |
1996-02-22 |
Myriad Genetics, Inc. |
Procede pour diagnostiquer une predisposition au cancer du sein et des ovaires
|
MX9701075A
(es)
|
1994-08-12 |
1998-03-31 |
Myriad Genetics Inc |
Mutaciones en vivo y polimorfismos en el gen de susceptibilidad al cancer de pecho y ovario enlazado con 17q.
|
US6376170B1
(en)
*
|
1994-10-03 |
2002-04-23 |
The Scripps Research Institute |
Ligand capture-directed selection of antibody
|
US5630924A
(en)
*
|
1995-04-20 |
1997-05-20 |
Perseptive Biosystems, Inc. |
Compositions, methods and apparatus for ultrafast electroseparation analysis
|
US20010051350A1
(en)
|
1995-05-02 |
2001-12-13 |
Albert Nazareth |
Diagnostic detection device and method
|
US5837492A
(en)
|
1995-12-18 |
1998-11-17 |
Myriad Genetics, Inc. |
Chromosome 13-linked breast cancer susceptibility gene
|
CA2240737C
(fr)
|
1995-12-22 |
2009-09-29 |
University Of Utah Research Foundation |
Gene du syndrome du q-t long codant kvlqt1 et son association avec mink
|
US5770086A
(en)
*
|
1996-01-25 |
1998-06-23 |
Eureka| Science Corp. |
Methods and apparatus using hydrogels
|
JP3706895B2
(ja)
|
1996-07-18 |
2005-10-19 |
ベーリングウエルケ、アクティエンゲゼルシャフト |
リガンド検定用試薬
|
DE69725118T2
(de)
*
|
1996-07-18 |
2004-07-08 |
Dade Behring Marburg Gmbh |
Reagentien für tests für mycophenolsäure
|
EP2065396A1
(fr)
|
1996-08-30 |
2009-06-03 |
Human Genome Sciences, Inc. |
Interleukine-19
|
US5879951A
(en)
*
|
1997-01-29 |
1999-03-09 |
Smithkline Diagnostics, Inc. |
Opposable-element assay device employing unidirectional flow
|
US5939252A
(en)
*
|
1997-05-09 |
1999-08-17 |
Lennon; Donald J. |
Detachable-element assay device
|
US6391547B1
(en)
*
|
1997-09-09 |
2002-05-21 |
Center For The Application Of Molecular Biology To International Agriculture |
Microbial β-glucuronidase genes, gene products and uses thereof
|
US7087420B1
(en)
|
1997-07-17 |
2006-08-08 |
Cambia |
Microbial β-glucuronidase genes, gene products and uses thereof
|
US5929049A
(en)
*
|
1997-08-08 |
1999-07-27 |
Dade Behring Marburg Gmbh |
Polysaccharide conjugates of biomolecules
|
JP4838932B2
(ja)
*
|
1997-08-21 |
2011-12-14 |
メイン メディカル センター |
過酸化物に基づく化学発光の検量方法、並びにそのために用いる化合物
|
CA2305625A1
(fr)
*
|
1997-09-29 |
1999-04-08 |
University Of Maryland, Baltimore |
Composants modifies de synthesome d'adn
|
US6824986B1
(en)
|
1997-10-06 |
2004-11-30 |
University Of Cincinnati |
Methods for measuring in vivo cytokine production
|
JP2002516061A
(ja)
|
1997-10-14 |
2002-06-04 |
ダーウィン モレキュラー コーポレイション |
チミジンキナーゼ変異体ならびにチミジンキナーゼ活性およびグアニル酸キナーゼ活性を有する融合タンパク質
|
US6180340B1
(en)
|
1997-10-31 |
2001-01-30 |
Gen-Probe Incorporated |
Extended dynamic range assays
|
US6153442A
(en)
*
|
1998-05-20 |
2000-11-28 |
Dade Behring Inc. |
Reagents and methods for specific binding assays
|
WO1999064603A2
(fr)
|
1998-06-12 |
1999-12-16 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
AUGMENTATION DE L'ACTIVATION DES CELLULES B ET DE LA SECRETION D'IMMUNOGLOBULINE PAR CO-STIMULATION DE RECEPTEURS DE L'ANTIGENE ET D'EBV Gp350/220
|
EP1105485B1
(fr)
*
|
1998-08-21 |
2006-07-05 |
Immunex Corporation |
Adn humain il-1 epsilon et polypeptides
|
GB9823397D0
(en)
*
|
1998-10-27 |
1998-12-23 |
Rsr Ltd |
Assays for thyroid autoantibodies
|
NZ552959A
(en)
|
1998-11-27 |
2008-06-30 |
Darwin Discovery Ltd |
Compositions and methods for increasing bone mineralization
|
US20040009535A1
(en)
|
1998-11-27 |
2004-01-15 |
Celltech R&D, Inc. |
Compositions and methods for increasing bone mineralization
|
CA2359075A1
(fr)
|
1999-02-19 |
2000-08-24 |
Michigan State University |
Test d'antigenes pour la detection de myeloencephalite protozoaire equine dans le serum et le liquide cephalorachidien equins
|
GB9903841D0
(en)
*
|
1999-02-20 |
1999-04-14 |
Imp College Innovations Ltd |
Diagnosis and treatment of cancer
|
US6911429B2
(en)
*
|
1999-04-01 |
2005-06-28 |
Transition Therapeutics Inc. |
Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans
|
US6864235B1
(en)
*
|
1999-04-01 |
2005-03-08 |
Eva A. Turley |
Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans
|
WO2000076538A1
(fr)
|
1999-06-10 |
2000-12-21 |
Michigan State University |
Calicivirus felin isole dans l'urine du chat et vaccins derives
|
US6537762B1
(en)
|
1999-07-30 |
2003-03-25 |
Board Of Trustees Of Michigan State University |
Peptide mimotope to mycotoxin deoxynivalenol and uses thereof
|
US7419668B1
(en)
|
1999-09-02 |
2008-09-02 |
Board Of Trustees Of Michigan State University |
Vaccine to control equine protozoal myeloencephalitis in horses
|
AU7108700A
(en)
|
1999-09-02 |
2001-03-26 |
Michigan State University |
Vaccine to control equine protozoal myeloencephalitis in horses
|
US6794132B2
(en)
|
1999-10-02 |
2004-09-21 |
Biosite, Inc. |
Human antibodies
|
US7135287B1
(en)
|
1999-10-02 |
2006-11-14 |
Biosite, Inc. |
Human antibodies
|
US20070111259A1
(en)
*
|
1999-10-02 |
2007-05-17 |
Medarex, Inc. |
Human antibodies
|
US6680209B1
(en)
*
|
1999-12-06 |
2004-01-20 |
Biosite, Incorporated |
Human antibodies as diagnostic reagents
|
US6528321B1
(en)
|
2000-06-26 |
2003-03-04 |
Beckman Coulter, Inc. |
Opposable-element chromatographic assay device for detection of analytes in whole blood samples
|
US20060029604A1
(en)
*
|
2000-06-28 |
2006-02-09 |
Gerngross Tillman U |
Immunoglobulins comprising predominantly a GlcNAc2Man3GlcNAc2 glycoform
|
US20060034830A1
(en)
*
|
2000-06-28 |
2006-02-16 |
Gerngross Tillman U |
Immunoglobulins comprising predominantly a GalGlcNAcMan5GLcNAc2 glycoform
|
US20060257399A1
(en)
*
|
2000-06-28 |
2006-11-16 |
Glycofi, Inc. |
Immunoglobulins comprising predominantly a Man5GIcNAc2 glycoform
|
US20060024304A1
(en)
*
|
2000-06-28 |
2006-02-02 |
Gerngross Tillman U |
Immunoglobulins comprising predominantly a Man5GlcNAc2 glycoform
|
US20060034828A1
(en)
*
|
2000-06-28 |
2006-02-16 |
Gerngross Tillman U |
Immunoglobulins comprising predominantly a GlcNAcMAN5GLCNAC2 glycoform
|
RU2286172C2
(ru)
*
|
2000-08-17 |
2006-10-27 |
Трипеп Аб |
Вакцины, содержащие рибавирин, и способы их использования
|
US6680059B2
(en)
*
|
2000-08-29 |
2004-01-20 |
Tripep Ab |
Vaccines containing ribavirin and methods of use thereof
|
US7022830B2
(en)
|
2000-08-17 |
2006-04-04 |
Tripep Ab |
Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
|
ES2296803T3
(es)
|
2000-08-17 |
2008-05-01 |
Tripep Ab |
Vacunas que contienen ribavirina.
|
WO2002050543A2
(fr)
*
|
2000-12-19 |
2002-06-27 |
Instrumentation Laboratory Co. |
Systeme de detection d'une substance a analyser libre
|
EP1385001A4
(fr)
*
|
2001-03-30 |
2007-07-25 |
Mitsubishi Kagaku Iatron Inc |
Reactif et procede pour l'immunoanalyse de l'elastase 1, et procede de detection de pathologie pancreatique
|
CA2443968A1
(fr)
|
2001-04-12 |
2002-10-24 |
Imperial College Innovations Limited |
Diagnostic et traitement du cancer
|
DE60228477D1
(de)
|
2001-05-08 |
2008-10-02 |
Darwin Molecular Corp |
Verfahren zur regulierung der immunfunktion in primaten unter verwendung des foxp3-proteins
|
EP1434993B1
(fr)
|
2001-09-18 |
2013-04-24 |
Fibrogen, Inc. |
Procedes permettant d'analyser le facteur de croissance du tissu conjonctif
|
AU2002330102A1
(en)
*
|
2001-09-28 |
2003-04-14 |
Aspenbio, Inc. |
Bovine pregnancy test
|
AU2002364894A1
(en)
*
|
2001-11-09 |
2003-06-30 |
Neurogenetics, Inc. |
Single nucleotide polymorphisms and mutations on alpha-2-macroglobulin
|
US20040067512A1
(en)
*
|
2001-11-09 |
2004-04-08 |
Neurogenetics, Inc. |
Single nucleotide polymorphisms and mutations on Alpha-2-Macroglobulin
|
US20060034829A1
(en)
*
|
2001-12-27 |
2006-02-16 |
Gerngross Tillman U |
Immunoglobulins comprising predominantly a MAN3GLCNAC2 glycoform
|
US20060024292A1
(en)
*
|
2001-12-27 |
2006-02-02 |
Gerngross Tillman U |
Immunoglobulins comprising predominantly a Gal2GlcNAc2Man3GlcNAc2 glycoform
|
US20030153011A1
(en)
*
|
2002-02-08 |
2003-08-14 |
Bell Michael L. |
Methods and reagents for conducting multiplexed assays of multiple analytes
|
US20030153094A1
(en)
*
|
2002-02-13 |
2003-08-14 |
Board Of Trustees Of Michigan State University |
Conductimetric biosensor device, method and system
|
US7294471B2
(en)
*
|
2002-02-27 |
2007-11-13 |
Cskeys, Llc |
Method for purifying cancer-specific proliferating cell nuclear antigen
|
WO2003093493A2
(fr)
*
|
2002-05-02 |
2003-11-13 |
Aspenbio, Inc. |
Detection de la gravidite
|
US20040101860A1
(en)
*
|
2002-11-27 |
2004-05-27 |
Jones Alison M. |
Predicting animal performance
|
US20040259226A1
(en)
*
|
2003-05-30 |
2004-12-23 |
Robey W. Wade |
Monitoring for and detecting microbes used in bioterrorism
|
US7335359B2
(en)
|
2003-02-06 |
2008-02-26 |
Tripep Ab |
Glycosylated specificity exchangers
|
KR20050099536A
(ko)
|
2003-02-06 |
2005-10-13 |
트리펩 아베 |
글리코실화된 특이성 교환체
|
US20040185446A1
(en)
*
|
2003-03-18 |
2004-09-23 |
Jones Alison M. |
Cpn60 targets for quantification of microbial species
|
US20040185434A1
(en)
*
|
2003-03-21 |
2004-09-23 |
Robey W. Wade |
Detecting microbial contamination in animal by-products
|
US20040185454A1
(en)
*
|
2003-03-21 |
2004-09-23 |
Jones Alison M. |
Identification and quantification of microbial species in a sample
|
US7321065B2
(en)
*
|
2003-04-18 |
2008-01-22 |
The Regents Of The University Of California |
Thyronamine derivatives and analogs and methods of use thereof
|
US20040241662A1
(en)
*
|
2003-05-30 |
2004-12-02 |
Robey W. Wade |
Detecting microbial contamination in grain and related products
|
ES2586401T3
(es)
|
2003-06-16 |
2016-10-14 |
Ucb Pharma S.A. |
Anticuerpos específicos para la esclerostina y métodos para aumentar la mineralización ósea
|
DE602004003632T2
(de)
*
|
2003-07-09 |
2007-10-25 |
Matsushita Electric Industrial Co., Ltd., Kadoma |
Turbidimetrisches Immuntestverfahren und zugehörige Vorrichtung
|
GB0317592D0
(en)
*
|
2003-07-26 |
2003-08-27 |
Astrazeneca Ab |
Method
|
US7163998B2
(en)
*
|
2003-09-09 |
2007-01-16 |
Eastman Kodak Company |
Stabilized polymer beads and method of preparation
|
JP4933258B2
(ja)
*
|
2003-09-22 |
2012-05-16 |
クイデル コーポレーション |
試料中の複数分析物の検出装置
|
US20050214882A1
(en)
*
|
2004-03-25 |
2005-09-29 |
Ez Bio Inc. |
Reagents, methods and kits for the universal rapid immuno-detection
|
AU2005278123B2
(en)
*
|
2004-04-16 |
2008-04-24 |
Idexx Laboratories, Inc. |
Canine Pancreatic Lipase
|
WO2005111083A2
(fr)
|
2004-04-29 |
2005-11-24 |
Otsuka Pharmaceutical Co., Ltd. |
Anticorps diriges contre la glycoproteine vi et procedes associes
|
DE102004038163A1
(de)
*
|
2004-08-06 |
2006-03-16 |
Diacdem Chip Technologies Gmbh |
Fluoreszenz-basierte Assays zur schnellen, quantitativen Analyse von Biomolekülen (Proteine und Nukleinsäuren) durch Anreicherung auf Zellen oder Beads
|
US7919093B2
(en)
|
2004-11-16 |
2011-04-05 |
Trustees Of Boston University |
Roles for dual endothelin-1/angiotensin II receptor (Dear) in hypertension and angiogenesis
|
WO2006068768A2
(fr)
|
2004-11-24 |
2006-06-29 |
Hanna Skubatch |
Methodes et compositions pour traiter des troubles
|
EA011154B1
(ru)
|
2004-12-08 |
2009-02-27 |
Сирион Терапьютикс, Инк. |
Композиции для лечения ретинол-ассоциированных заболеваний
|
CA2531616A1
(fr)
*
|
2004-12-28 |
2006-06-28 |
Kabushiki Kaisha Kobe Seiko Sho (Kobe Steel, Ltd.) |
Tole mince d'acier a haute resistance mecanique possedant une resistance elevee a la fragilisation par l'hydrogene et une grande aptitude a l'usinage
|
EP1872135A2
(fr)
*
|
2005-03-15 |
2008-01-02 |
Applera Corporation |
Utilisation de systemes d'antigenes a substituts d'anticorps a des fins de detection d'analytes
|
WO2007031867A2
(fr)
|
2005-05-25 |
2007-03-22 |
Tripep Ab |
Gene de fusion ns3/4a non structurel de l'hepatite c
|
CA2617341C
(fr)
*
|
2005-07-28 |
2011-03-29 |
Pfizer Products Inc. |
Procedes d'administration de vaccins, nouveaux calicivirus felins, et traitements pour immuniser des animaux contre le parvovirus felin et contre l'herpes-virus felin
|
JP2009504659A
(ja)
*
|
2005-08-08 |
2009-02-05 |
オンコノン・リミテッド・ライアビリティ・カンパニー |
抗体組成物、腫瘍性疾患の処置方法、および受胎能の調節方法
|
JP2009507482A
(ja)
*
|
2005-09-09 |
2009-02-26 |
グライコフィ, インコーポレイテッド |
主にman7glcnac2、man8glcnac2グリコフォームを含むイムノグロブリン
|
WO2007053570A2
(fr)
*
|
2005-10-31 |
2007-05-10 |
Janssen Pharmaceutica N.V. |
Complexe polypeptidique de trpm8 et de calmoduline et tissus correspondants
|
WO2007062359A1
(fr)
*
|
2005-11-21 |
2007-05-31 |
Oregon Health & Science University |
Methodes et reactifs pour l'elimination ou la reduction de faux positifs dans l'analyse d'un echantillon
|
KR20080085093A
(ko)
*
|
2006-01-12 |
2008-09-22 |
얀센 파마슈티카 엔.브이. |
키마아제에 의한 slpi의 프로세싱
|
ATE485517T1
(de)
|
2006-03-22 |
2010-11-15 |
Viral Logic Systems Technology |
Verfahren zur identifizierung von polypeptid- targets
|
EP2006685A1
(fr)
*
|
2006-03-31 |
2008-12-24 |
Nissui Pharmaceutical Co., Ltd. |
Kit de réactif pour la réaction d'agglutination immune et procédé pour tester l'antigène
|
EP2010567A2
(fr)
*
|
2006-04-07 |
2009-01-07 |
The Government of the United States of America as Represented by The Department of Health and Human Services |
Compositions d'anticorps et méthodes de traitement d'une maladie néoplasique
|
GB0607462D0
(en)
*
|
2006-04-13 |
2006-05-24 |
Avecia Ltd |
Assay
|
EP2027151A2
(fr)
*
|
2006-05-15 |
2009-02-25 |
Viral Logic Systems Technology Corp. |
Compositions associées au cd47 et procédés destinés au traitement de maladies et de troubles immunologiques
|
US8377448B2
(en)
*
|
2006-05-15 |
2013-02-19 |
The Board Of Trustees Of The Leland Standford Junior University |
CD47 related compositions and methods for treating immunological diseases and disorders
|
US20100159450A1
(en)
|
2006-06-23 |
2010-06-24 |
Susanne Wagner |
Dpyd gene variants and use thereof
|
JP5420414B2
(ja)
|
2006-10-06 |
2014-02-19 |
シリゲン グループ リミテッド |
指向性バイオマーカシグナル増幅用の蛍光方法および材料
|
US20080125368A1
(en)
*
|
2006-10-31 |
2008-05-29 |
Imperial Innovations Limited |
Methods
|
EP2913341A1
(fr)
|
2006-12-22 |
2015-09-02 |
University of Utah Research Foundation |
Procédé de détection de maladies et d'états pathologiques oculaires et traitement de ceux-ci
|
US20090092631A1
(en)
*
|
2007-03-26 |
2009-04-09 |
Tripep Ab |
Glycosylated specificity exchangers that induce an antibody dependent cellular cytotoxicity (adcc) response
|
EP2140269B1
(fr)
|
2007-03-27 |
2013-11-20 |
Immunovia AB |
Procédé, assemblage et utilisation de celui-ci
|
GB0709092D0
(en)
*
|
2007-05-11 |
2007-06-20 |
Borrebaeck Carl |
Diagnosis and method of disease
|
US8936946B2
(en)
|
2007-06-20 |
2015-01-20 |
Board Of Trustees Of Michigan State University |
Biologically enhanced electrically-active magnetic nanoparticles for concentration, separation, and detection applications
|
EP2185195A2
(fr)
|
2007-08-16 |
2010-05-19 |
Tripep Ab |
Plate-forme immunogène
|
JP2009085703A
(ja)
*
|
2007-09-28 |
2009-04-23 |
Fujifilm Corp |
高感度免疫測定方法
|
US7771960B2
(en)
*
|
2007-10-15 |
2010-08-10 |
Idexx Laboratories, Inc. |
Feline pancreatic lipase
|
WO2009130588A2
(fr)
*
|
2008-04-22 |
2009-10-29 |
Tripep Ab |
Plateforme immunogène
|
WO2010030167A2
(fr)
|
2008-09-12 |
2010-03-18 |
Cancer Research Initiative Foundation |
Procédé de détection et diagnostic de cancers buccaux et rhino-pharyngiens
|
CA2738621C
(fr)
*
|
2008-10-02 |
2017-01-31 |
Pharmathene Inc. |
Formulation de vaccin contre le charbon et ses utilisations
|
CA2744555A1
(fr)
|
2008-11-26 |
2010-06-03 |
Five Prime Therapeutics, Inc. |
Compositions et procedes pour reguler l'expression de collagene et d'actine de muscle lisse par la serpine e2
|
US20100183675A1
(en)
*
|
2009-01-22 |
2010-07-22 |
Allan Watkinson |
Stable vaccine compositions and methods of use
|
EP3301446B1
(fr)
|
2009-02-11 |
2020-04-15 |
Caris MPI, Inc. |
Profilage moléculaire de tumeurs
|
SG177355A1
(en)
|
2009-06-26 |
2012-02-28 |
Sirigen Inc |
Signal amplified biological detection with conjugated polymers
|
CA2768391C
(fr)
|
2009-07-21 |
2016-09-06 |
Gen-Probe Incorporated |
Procedes et compositions pour la detection quantitative de sequences d'acides nucleiques sur une gamme dynamique etendue
|
US20160186266A1
(en)
|
2009-10-27 |
2016-06-30 |
Carislife Sciences, Inc. |
Molecular profiling for personalized medicine
|
EP3981819B1
(fr)
|
2010-01-19 |
2024-02-28 |
Sirigen II Limited |
Nouveaux réactifs pour l'amplification dirigée d'un signal de biomarqueur
|
US20130190237A1
(en)
|
2010-04-07 |
2013-07-25 |
Imperial Innovations Limited |
Methods for categorising cancer such as breast cancer
|
GB201009798D0
(en)
|
2010-06-11 |
2010-07-21 |
Immunovia Ab |
Method,array and use thereof
|
WO2012071096A2
(fr)
|
2010-09-03 |
2012-05-31 |
The Johns Hopkins University |
Mutations arid1a et ppp2r1a dans le cancer
|
GB201014837D0
(en)
|
2010-09-07 |
2010-10-20 |
Immunovia Ab |
Biomarker signatures and uses thereof
|
EP2444084A1
(fr)
|
2010-10-21 |
2012-04-25 |
Centro Nacional de Investigaciones Oncológicas (CNIO) |
Utilisation d'inhibiteurs de PI3K pour le traitement de l'obésité
|
GB201018014D0
(en)
|
2010-10-26 |
2010-12-08 |
Senzagen Ab |
Analytical methods and arrays for use in the same
|
JP2014510721A
(ja)
|
2011-02-15 |
2014-05-01 |
イミューン デザイン コーポレイション |
ベクターワクチンによる免疫原特異的免疫応答を強化するための方法
|
GB201103726D0
(en)
|
2011-03-04 |
2011-04-20 |
Immunovia Ab |
Method, array and use thereof
|
MX350795B
(es)
|
2011-04-08 |
2017-09-19 |
Inmune Design Corp |
Composiciones inmunogenicas y metodos para utilizar las composiciones para inducir respuestas inmunes humorales y celulares.
|
WO2012142164A1
(fr)
|
2011-04-12 |
2012-10-18 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Anticorps monoclonaux humains qui se lient aux facteurs de croissance insulinomimétique (igf) de type i et ii
|
CN103597351A
(zh)
*
|
2011-05-23 |
2014-02-19 |
积水医疗株式会社 |
抑制pivka-ii测定试剂中非特异性反应的方法
|
US8859297B2
(en)
|
2011-05-23 |
2014-10-14 |
Board Of Trustees Of Michigan State University |
Detection of conductive polymer-labeled analytes
|
US10739337B2
(en)
|
2011-08-30 |
2020-08-11 |
Board Of Trustees Of Michigan State University |
Extraction and detection of pathogens using carbohydrate-functionalized biosensors
|
ES2687951T3
(es)
|
2011-10-14 |
2018-10-30 |
F. Hoffmann-La Roche Ag |
Anticuerpos anti-HtrA1 y procedimientos de uso
|
WO2013071119A2
(fr)
|
2011-11-10 |
2013-05-16 |
Genentech, Inc |
Méthodes pour traiter, diagnostiquer et surveiller la maladie d'alzheimer
|
AU2012346540C1
(en)
|
2011-11-30 |
2019-07-04 |
Genentech, Inc. |
ErbB3 mutations in cancer
|
CA2858099C
(fr)
|
2011-12-22 |
2020-12-15 |
Glycomimetics, Inc. |
Composes antagonistes de la selectine e, compositions et methodes d'utilisation
|
GB201207297D0
(en)
|
2012-04-26 |
2012-06-06 |
Senzagen Ab |
Analytical methods and arrays for use in the same
|
US20140056901A1
(en)
|
2012-08-21 |
2014-02-27 |
The Institute For Molecular Medicine |
Anti-tau antibodies and compositions for and methods of making and using in treatment, diagnosis and monitoring of tauopathies
|
WO2014089269A1
(fr)
|
2012-12-07 |
2014-06-12 |
Glycomimetics, Inc. |
Composés, compositions et procédés utilisant des antagonistes d'e-sélectine pour la mobilisation de cellules hématopoïétiques
|
GB201305940D0
(en)
|
2013-04-02 |
2013-05-15 |
Immunovia Ab |
Methods and arrays for use in the same
|
GB201306147D0
(en)
|
2013-04-05 |
2013-05-22 |
Univ Ha Il |
Novel biomarker signature and uses thereof
|
GB201319878D0
(en)
|
2013-11-11 |
2013-12-25 |
Immunovia Ab |
Method, Array and use thereof
|
CA2928014A1
(fr)
|
2013-11-15 |
2015-05-21 |
Institut Pasteur |
Methode de detection d'un marqueur moleculaire de plasmodium falciparum resistant a l'artemisinine
|
EP2960252A1
(fr)
|
2014-06-26 |
2015-12-30 |
Institut Pasteur |
Phospholipase pour le Traitment d'immunosuppression
|
CR20160369A
(es)
|
2014-01-21 |
2016-10-05 |
Immune Desing Corp |
Composiciones para uso en el tratamiento de afecciones alérgicas
|
BR112016018521A2
(pt)
|
2014-02-14 |
2017-10-17 |
Immune Design Corp |
composição, e, kit.
|
IL248511B
(en)
|
2014-05-13 |
2022-07-01 |
Bavarian Nordic As |
Combined therapy for the treatment of cancer with a focovirus expressing the antigen and a monoclonal antibody against tim-3
|
GB201410226D0
(en)
|
2014-06-09 |
2014-07-23 |
Immunovia Ab |
Methods and arrays for use in the same
|
MX2017000630A
(es)
|
2014-07-15 |
2017-04-27 |
Immune Design Corp |
Regimenes de sensibilización-refuerzo con un adyuvante de agonista tlr4 y un vector lentiviral.
|
JP6940406B2
(ja)
|
2014-07-25 |
2021-09-29 |
テラベクティTheravectys |
キメラ抗原レセプター分子の制御的発現のためのレンチウイルスベクター
|
JP6767374B2
(ja)
|
2014-10-20 |
2020-10-14 |
ジェン−プローブ・インコーポレーテッド |
赤血球溶解溶液
|
US9107906B1
(en)
|
2014-10-28 |
2015-08-18 |
Adma Biologics, Inc. |
Compositions and methods for the treatment of immunodeficiency
|
WO2016170022A1
(fr)
|
2015-04-21 |
2016-10-27 |
Institut Gustave Roussy |
Procédés thérapeutiques, produits et compositions inhibant znf555
|
EP3341725B1
(fr)
|
2015-08-25 |
2021-08-18 |
Prothena Biosciences Limited |
Procédés de détection d'alpha-synucléine phosphorylée
|
GB201516801D0
(en)
|
2015-09-22 |
2015-11-04 |
Immunovia Ab |
Method, array and use thereof
|
KR102162324B1
(ko)
|
2015-10-30 |
2020-10-07 |
제넨테크, 인크. |
항-HtrA1 항체 및 이의 사용 방법
|
WO2017075061A1
(fr)
|
2015-10-30 |
2017-05-04 |
Exact Sciences Corporation |
Détection par amplification multiplexée et isolement et détection d'adn issu de plasma
|
EP3410849B1
(fr)
|
2016-02-05 |
2023-07-05 |
Institut Pasteur |
Utilisation d'inhibiteurs d'adam12 comme adjuvants dans les traitement antitumoraux
|
EP4339288A3
(fr)
|
2016-03-18 |
2024-06-05 |
Caris Science, Inc. |
Sondes oligonucleotidiques et leurs utilisations
|
GB201700138D0
(en)
|
2017-01-05 |
2017-02-22 |
Senzagen Ab |
Analytical methods and arrays for use in the same
|
WO2017162773A1
(fr)
|
2016-03-23 |
2017-09-28 |
Senzagen Ab |
Procédés analytiques et puces à utiliser dans lesdits procédés
|
KR102438354B1
(ko)
|
2016-04-15 |
2022-08-31 |
베크만 컬터, 인코포레이티드 |
광활성 거대분자 및 그의 용도
|
DE202017007129U1
(de)
|
2016-04-27 |
2019-08-29 |
Gen-Probe Incorporated |
Lysereagenz für Blutzellen
|
GB201608192D0
(en)
|
2016-05-10 |
2016-06-22 |
Immunovia Ab |
Method, array and use thereof
|
AU2017271579B2
(en)
|
2016-05-25 |
2023-10-19 |
Caris Science, Inc. |
Oligonucleotide probes and uses thereof
|
GB201609950D0
(en)
|
2016-06-07 |
2016-07-20 |
Immunovia Ab |
Biomarkers signatures and uses thereof
|
GB201609951D0
(en)
|
2016-06-07 |
2016-07-20 |
Immunovia Ab |
Biomarkers signatures and uses thereof
|
ES2919927T3
(es)
|
2016-08-10 |
2022-07-29 |
Pasteur Institut |
Métodos y reactivos para la detección del paludismo por Plasmodium falciparum resistente a la piperaquina
|
GB201701572D0
(en)
|
2017-01-31 |
2017-03-15 |
Immunovia Ab |
Methods, arrays and uses thereof
|
WO2018148180A2
(fr)
|
2017-02-07 |
2018-08-16 |
Immune Design Corp. |
Matériaux et méthodes pour l'identification et le traitement du cancer
|
US10259865B2
(en)
|
2017-03-15 |
2019-04-16 |
Adma Biologics, Inc. |
Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
|
WO2018200505A1
(fr)
|
2017-04-24 |
2018-11-01 |
Genentech, Inc. |
Mutations erbb2/her2 dans le domaine transmembranaire ou juxtamembranaire
|
GB201706464D0
(en)
|
2017-04-24 |
2017-06-07 |
Senzagen Ab |
Analytical methods and arrays for use in the same
|
GB201715445D0
(en)
|
2017-09-25 |
2017-11-08 |
Senzagen Ab |
Novel cell line and uses thereof
|
US20200331975A1
(en)
|
2017-10-20 |
2020-10-22 |
Institut Curie |
Dap10/12 based cars adapted for rush
|
CN111587123A
(zh)
|
2017-11-09 |
2020-08-25 |
品通治疗有限公司 |
用于生成和使用人源化构象特异性磷酸化的τ抗体的方法和组合物
|
EP3530282A1
(fr)
|
2018-02-27 |
2019-08-28 |
Diaccurate |
Procédés thérapeutiques
|
WO2020070303A1
(fr)
|
2018-10-05 |
2020-04-09 |
Bavarian Nordic A/S |
Polythérapie pour le traitement du cancer comprenant une administration intraveineuse de mva recombiné et d'un antagoniste ou d'un agoniste d'un point de contrôle immunitaire
|
SG11202104918PA
(en)
|
2018-11-20 |
2021-06-29 |
Bavarian Nordic As |
Therapy for treating cancer with an intratumoral and/or intravenous administration of a recombinant mva encoding 4-1bbl (cd137l) and/or cd40l
|
CA3121170A1
(fr)
|
2018-11-30 |
2020-06-04 |
Caris Mpi, Inc. |
Profilage moleculaire de nouvelle generation
|
BR102019025989A2
(pt)
|
2018-12-14 |
2020-06-23 |
Beckman Coulter, Inc. |
Modificação de corantes poliméricos e aplicações
|
CN113260715A
(zh)
|
2019-01-03 |
2021-08-13 |
森扎基因有限责任公司 |
识别能够诱发呼吸道致敏的试剂的方法和用于该方法的阵列和分析试剂盒
|
EP3693063A1
(fr)
|
2019-02-06 |
2020-08-12 |
Diaccurate |
Procédés et compositions de traitement du cancer
|
GB201904472D0
(en)
|
2019-03-29 |
2019-05-15 |
Immunovia Ab |
Methods, arrays and uses thereof
|
US20220251179A1
(en)
|
2019-05-28 |
2022-08-11 |
Shanghaitech University |
Composition and methods to treat ectodermal dysplasia 2, clouston type
|
WO2021099586A1
(fr)
|
2019-11-20 |
2021-05-27 |
Bavarian Nordic A/S |
Virus mva recombinants pour l'administration intratumorale et/ou intraveineuse pour le traitement du cancer
|
WO2021112918A1
(fr)
|
2019-12-02 |
2021-06-10 |
Caris Mpi, Inc. |
Prédicteur de réponse au platine dans une approche pan-cancer
|
US11815513B2
(en)
|
2020-04-01 |
2023-11-14 |
Institut Pasteur |
Severe acute respiratory syndrome (SARS)-associated coronavirus diagnostics
|
US20210311054A1
(en)
|
2020-04-01 |
2021-10-07 |
Institut Pasteur |
Severe acute respiratory syndrome (sars) - associated coronavirus diagnostics
|
WO2021205228A1
(fr)
|
2020-04-07 |
2021-10-14 |
Abbott Rapid Diagnostics International Unlimited Company |
Dispositif de dosage
|
WO2021209824A1
(fr)
|
2020-04-17 |
2021-10-21 |
Institut Pasteur |
Procédés et produits pour l'analyse sérologique d'une infection par le sars-cov-2
|
WO2021239666A1
(fr)
|
2020-05-26 |
2021-12-02 |
Diaccurate |
Procédés thérapeutiques
|
WO2021242674A1
(fr)
*
|
2020-05-26 |
2021-12-02 |
Ptc Therapeutics, Inc. |
Quantification de dystrophine
|
EP4179333A1
(fr)
|
2020-07-10 |
2023-05-17 |
Institut Pasteur |
Utilisation de gdf11 pour diagnostiquer et traiter l'anxiété et la dépression
|
GB202010970D0
(en)
|
2020-07-16 |
2020-09-02 |
Immunovia Ab |
Methods, arrays and uses thereof
|
US20240053339A1
(en)
|
2020-09-21 |
2024-02-15 |
Theravectys |
High throughput methods and products for sars-cov-2 sero-neutralization assay
|
EP4244625A1
(fr)
|
2020-11-13 |
2023-09-20 |
Beckman Coulter, Inc. |
Adjuvants de réduction d'interactions non spécifiques entre des conjugués polymères fluorescents et des cellules d'un échantillon biologique
|
JP2024509725A
(ja)
|
2021-02-05 |
2024-03-05 |
ベックマン コールター, インコーポレイテッド |
ポリマー色素-抗体コンジュゲート間の非特異的相互作用を阻止する組成物および方法
|
GB202104422D0
(en)
|
2021-03-29 |
2021-05-12 |
Orre Lukas |
Methods
|
US20230393130A1
(en)
|
2021-04-08 |
2023-12-07 |
Abbott Rapid Diagnostics International Unlimited Company |
Assay device
|
WO2022235705A1
(fr)
|
2021-05-04 |
2022-11-10 |
Beckman Coulter, Inc. |
Polymères absorbant les uv, compositions et utilisations de ceux-ci
|
WO2023056460A1
(fr)
|
2021-09-30 |
2023-04-06 |
Beckman Coulter, Inc. |
Polymères fluorescents à base de tétrahydropyrène hydrosolubles
|
WO2023118508A1
(fr)
|
2021-12-23 |
2023-06-29 |
Bavarian Nordic A/S |
Virus mva recombinants pour administration intrapéritonéale pour le traitement du cancer
|
WO2023150652A1
(fr)
|
2022-02-04 |
2023-08-10 |
Abbott Laboratories |
Procédés d'écoulement latéral, dosages et dispositifs de détection de la présence ou de mesure de la quantité d'ubiquitine carboxy-terminal hydrolase l1 et/ou d'une protéine gliofibrillaire acide dans un échantillon
|
WO2023223092A1
(fr)
|
2022-05-18 |
2023-11-23 |
Institut Pasteur |
Identification d'un circovirus humain
|
WO2024007016A2
(fr)
|
2022-07-01 |
2024-01-04 |
Beckman Coulter, Inc. |
Nouveaux colorants fluorescents et polymères issus de dérivés de dihydrophenanthrène
|
WO2024044327A1
(fr)
|
2022-08-26 |
2024-02-29 |
Beckman Coulter, Inc. |
Monomères dhnt et colorants polymères ayant des propriétés photophysiques modifiées
|